Overview: Global and Local Impact of Antibiotic Resistance, Infect Dis Clin North Am, vol.30, issue.2, p.27208761, 2016. ,
APD: the Antimicrobial Peptide Database, Nucleic Acids Res, vol.32, p.14681488, 2004. ,
Antimicrobial peptides with cell-penetrating peptide properties and vice versa, Eur Biophys J, vol.40, issue.4, p.21336522, 2011. ,
Antimicrobial peptide mimics for improved therapeutic properties, Biochim Biophys Acta, vol.1788, issue.8, p.19028449, 2009. ,
Antimicrobial peptides stage a comeback, Nat Biotechnol, vol.31, issue.5, p.23657384, 2013. ,
Antimicrobial peptides and their analogs: searching for new potential therapeutics, Perspect Medicin Chem, vol.6, p.25374459, 2014. ,
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect Dis, vol.16, issue.2, p.26603172, 2016. ,
Pituitary adenylate cyclaseactivating polypeptide and its receptors: 20 years after the discovery, Pharmacol Rev, vol.61, issue.3, pp.283-357, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-02058111
Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide, Curr Med Chem, vol.16, issue.33, p.19835562, 2009. ,
Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide, Biochim Biophys Acta, vol.1823, issue.4, p.22343001, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00819026
Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide, J Control Release, vol.163, issue.2, p.22922050, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00818553
, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th ed. CLSI document M7-A7, 2006.
Proteomic identification and characterization of bacterial factors associated with Burkholderia cenocepacia survival in a murine host, Microbiology, vol.153, p.17185549, 2007. ,
Methods for general and molecular bacteriology, p.791, 1994. ,
New insights about the peculiar role of the 28-38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection, Biochem Pharmacol, vol.154, p.29704474, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01856091
Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation, J Chem Theory Comput, vol.4, issue.3, pp.435-482, 2008. ,
DOI : 10.1021/ct700301q
A biomolecular force field based on the free enthalpy of hydration and solvation: the GROMOS force-field parameter sets 53A5 and 53A6, J Comput Chem, vol.25, issue.13, p.15264259, 2004. ,
Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature, Biophys J, vol.72, issue.5, p.9129804, 1997. ,
LINCS: A linear constraint solver for molecular simulations, J Comp Chem, vol.18, pp.1463-72, 1997. ,
Particle mesh Ewald: An N?log(N) method for Ewald sums in large systems, J Chem Phys, vol.98, pp.10089-92, 1993. ,
Dictionary of protein secondary structure: pattern recognition of hydrogenbonded and geometrical features, Biopolymers, vol.22, issue.12, p.6667333, 1983. ,
Novel stable PACAP analogs with potent activity towards the PAC1 receptor, Peptides, vol.29, issue.6, p.18353507, 2008. ,
Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor, J Med Chem, vol.52, issue.10, p.19413310, 2009. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00819957
Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution, J Biomol NMR, vol.9, issue.2, p.9090128, 1997. ,
Comparative analysis of the Burkholderia cenocepacia K56-2 essential genome reveals cell envelope functions that are uniquely required for survival in species of the genus, Burkholderia. Microb Genom, vol.3, issue.11, 2017. ,
Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug, Curr Pharm Des, vol.17, issue.10, p.21524253, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00819519
Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects, Biochem Pharmacol, vol.81, issue.4, p.21114961, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00819506
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence, Clin Microbiol Infect, vol.16, issue.7, p.20880411, 2010. ,
Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis, Am J Respir Med, vol.2, issue.4, p.14719998, 2003. ,
Asymmetric phospholipid: lipopolysaccharide bilayers; a Gram-negative bacterial outer membrane mimic, J R Soc Interface, vol.10, issue.89, p.24132206, 2013. ,
DOI : 10.1098/rsif.2013.0810
URL : http://rsif.royalsocietypublishing.org/content/10/89/20130810.full.pdf
Structure and dynamics of a fusion peptide helical hairpin on the membrane surface: comparison of molecular simulations and NMR, J Phys Chem B, vol.118, issue.17, p.24712538, 2014. ,
The bacterial cell envelope, Cold Spring Harb Perspect Biol, vol.2, issue.5, p.20452953, 2010. ,
Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP, FEBS Lett, vol.588, issue.24, pp.4590-4596, 2014. ,